{"Symbol": "TECH", "AssetType": "Common Stock", "Name": "Bio-Techne Corp", "Description": "Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.", "CIK": "842023", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "614 MCKINLEY PLACE N.E., MINNEAPOLIS, MN, UNITED STATES, 55413", "OfficialSite": "https://www.bio-techne.com", "FiscalYearEnd": "June", "LatestQuarter": "2025-12-31", "MarketCapitalization": "9376246000", "EBITDA": "330537000", "PERatio": "113.08", "PEGRatio": "0.827", "BookValue": "12.9", "DividendPerShare": "0.32", "DividendYield": "0.0054", "EPS": "0.53", "RevenuePerShareTTM": "7.79", "ProfitMargin": "0.0667", "OperatingMarginTTM": "0.197", "ReturnOnAssetsTTM": "0.0652", "ReturnOnEquityTTM": "0.0397", "RevenueTTM": "1215578000", "GrossProfitTTM": "809634000", "DilutedEPSTTM": "0.53", "QuarterlyEarningsGrowthYOY": "0.091", "QuarterlyRevenueGrowthYOY": "-0.004", "AnalystTargetPrice": "75.25", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "10", "AnalystRatingHold": "5", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "113.08", "ForwardPE": "30.3", "PriceToSalesRatioTTM": "7.71", "PriceToBookRatio": "4.662", "EVToRevenue": "7.86", "EVToEBITDA": "42.05", "Beta": "1.469", "52WeekHigh": "72.06", "52WeekLow": "45.74", "50DayMovingAverage": "63.32", "200DayMovingAverage": "56.9", "SharesOutstanding": "156453000", "SharesFloat": "154577000", "PercentInsiders": "0.283", "PercentInstitutions": "112.245", "DividendDate": "2026-02-27", "ExDividendDate": "2026-02-13"}